topotecan has been researched along with Meningeal Carcinomatosis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fleming, GF; Lukas, RV; Salgia, S | 1 |
| Kiewe, P; Korfel, A; Reinwald, M; Thiel, E | 1 |
2 other study(ies) available for topotecan and Meningeal Carcinomatosis
| Article | Year |
|---|---|
Leptomeningeal carcinomatosis from breast cancer treated with intrathecal topotecan with concomitant intravenous eribulin.
Topics: Antineoplastic Agents; Breast Neoplasms; Female; Furans; Humans; Injections, Intravenous; Injections, Spinal; Ketones; Meningeal Carcinomatosis; Middle Aged; Topotecan | 2014 |
Topotecan and ifosfamide systemic chemotherapy for CNS involvement of solid tumors.
Topics: Aged; Antineoplastic Agents, Alkylating; Central Nervous System Neoplasms; Female; Humans; Ifosfamide; Karnofsky Performance Status; Male; Meningeal Carcinomatosis; Middle Aged; Topoisomerase I Inhibitors; Topotecan | 2011 |